News stories about Microbot Medical (NASDAQ:MBOT) have been trending somewhat positive this week, Accern Sentiment reports. The research firm identifies negative and positive news coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Microbot Medical earned a media sentiment score of 0.17 on Accern’s scale. Accern also assigned news stories about the biotechnology company an impact score of 45.3936317128209 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.
These are some of the headlines that may have impacted Accern’s scoring:
- Microbot Medical Inc. (NASDAQ: MBOT) – Hot Mover of the Day – Alpha Beta Stock (alphabetastock.com)
- Know the Secrets in Technical Analysis of Microbot Medical Inc. (MBOT) – Wall Street Morning (wallstreetmorning.com)
- Here’s What to Focus on – Microbot Medical Inc. (NASDAQ: MBOT) – The Investor Guide (wallstreetnews24.com)
- Microbot Medical Inc. (NASDAQ: MBOT) – Facts About In Play Stocks – Alpha Beta Stock (alphabetastock.com)
- Microbot Medical Inc. (NASDAQ: MBOT) – Glistening Stock’s Review – Alpha Beta Stock (alphabetastock.com)
Shares of Microbot Medical (NASDAQ MBOT) remained flat at $$1.04 during midday trading on Monday. 379,500 shares of the stock traded hands, compared to its average volume of 883,814. Microbot Medical has a twelve month low of $1.00 and a twelve month high of $9.94.
COPYRIGHT VIOLATION NOTICE: “Somewhat Positive News Coverage Somewhat Unlikely to Affect Microbot Medical (MBOT) Share Price” was originally reported by Week Herald and is the sole property of of Week Herald. If you are reading this report on another site, it was illegally copied and republished in violation of US & international copyright legislation. The correct version of this report can be viewed at https://weekherald.com/2017/12/25/somewhat-positive-news-coverage-somewhat-unlikely-to-affect-microbot-medical-mbot-share-price-2.html.
About Microbot Medical
Microbot Medical Inc, formerly StemCells, Inc, is a medical device company. The Company specializes in the researching, designing, developing and commercializing transformational micro-robotic medical technologies leveraging the artificial and natural lumens within the human body. It is engaged in developing its two product candidates: the Self Cleaning Shunt (SCS) for the treatment of hydrocephalus and normal pressure hydrocephalus (NPH), and TipCAT, a self-propelling, semi-disposable endoscope that the Company is developing for use in colonoscopy procedures.
Receive News & Ratings for Microbot Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbot Medical and related companies with MarketBeat.com's FREE daily email newsletter.